Latest Comments on Andrew Vaino's Articles

1. Matthew D’Ambrosio on Critical Therapeutics Awaits FDA Decision on New Zyflo Formulation: You might want to re-think how one chooses stocks on small,... more »
2. dcappe10 on Dendreon: Thinking Strategically Ahead of the FDA Review: Great Post! I would like to share an article with anyone... more »
3. Mike Trilivas on Dendreon: Short Term Volatility For This Biotech Stock: Neurochem's case is different that Dendereon's. Neurochem had... more »
4. jimmy Turano on Neurochem Dives As FDA Delays Decision On Kidney Drug: April 24th, Giving the fact that Cramer loves 'nstk and said 'it... more »
5. dorotie97 on Dendreon: Thinking Strategically Ahead of the FDA Review: “Whether Provenge is approved or not is very speculative.... more »